IP Library Granted Patent US 12,239,983
Granted Patent B2
US 12,239,983 · App. 18/020,692 · Granted Mar 4, 2025

Heaters for medical devices

Inventor: Ralph Lamble (Abingdon, GB)
Assignee: Sense Biodetection Limited
B01L3/502761B01L3/5023B01L3/50273B01L7/52G01K1/14H05K1/021H05K1/0212H05K7/2049B01L2200/0621B01L2200/0647B01L2200/10B01L2200/14B01L2200/147B01L2200/16B01L2300/042B01L2300/0636B01L2300/0825B01L2300/0861B01L2300/12B01L2300/1827B01L2400/0406B01L2400/0478B01L2400/0633B01L2400/0644
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,983
App. No.
18/020,692
Granted
Mar 4, 2025
Kind
B2
Abstract

A medical device comprising a multilayer printed circuit board (PCB) comprising a heating element on an inner layer of the PCB; a single cell electrical power source to power the heating element; and a chamber adapted to contain a liquid, at least part of said chamber being defined by a thermally conductive material configured to provide a thermal transfer interface between the chamber and the PCB.

Claims (19)

1. A medical device comprising: a multilayer printed circuit board (PCB) comprising a heating element on an inner layer of the PCB; a single-cell electrical power source to power the heating element; and a chamber adapted to contain a liquid, at least part of the chamber being defined by a thermally conductive material configured to provide a thermal transfer interface between the chamber and the PCB, wherein the interface between the thermally conductive material and the PCB comprises a larger surface area than the area of the chamber defined by the thermally conductive material.

2. The medical device according to claim 1 , wherein the PCB also comprises control electronics for the device.

3. The medical device according to claim 1 , wherein the heating element is disposed on an inner layer of the PCB.

4. The medical device according to claim 1 , wherein the heating element comprises a trace coil.

5. The medical device according to claim 1 , wherein the thermally conductive material comprises a sheet of thermally conductive material.

6. The medical device according to claim 1 , wherein the chamber comprises at least one substantially planar surface which is defined by the thermally conductive material.

7. The medical device according to claim 1 , which further comprises a temperature sensor thermally coupled to the chamber.

8. The medical device according to claim 7 , wherein the temperature sensor is located on the PCB and a thermally conductive element thermally couples the temperature sensor to the thermally conductive material.

9. The medical device according to claim 1 , further comprises a temperature controller, such as Proportional Integral (PI) or Proportional Integral Derivative (PID) controller.

10. The medical device of claim 1 , further comprising biasing means to urge the PCB into contact with the thermally conductive material.

11. The medical device according to claim 10 , wherein the biasing means is located between the PCB and a device casing within which the chamber and the PCB are housed.

12. The medical device according to claim 1 , wherein the single cell power source comprises a AAA battery.

13. The medical device according to claim 1 , wherein the electrical resistance of the heating element within the PCB is substantially the same as an internal electrical resistance of the power source.

14. The medical device according to claim 1 , which comprises a plurality of chambers at least part of each of which is defined by a thermally conductive material.

15. The medical device according to claim 14 , wherein the thermally conductive material defining at least part of the plurality of chambers is continuous between the plurality of chambers.

16. The medical device according to claim 1 , comprising at least one of a diagnostic device and a medical delivery device.

17. The medical device according to claim 1 , wherein the chamber comprises at least one of a reaction chamber and a medicament chamber.

18. The medical device according to claim 5 , wherein the sheet of thermally conductive material comprises a metallic foil.

19. The medical device according to claim 10 , wherein the chamber comprises a nucleic acid amplification reaction chamber, and biasing means forms an integral part of the device casing.

Assignments (5)
TERMINATION OF IP SECURITY AGREEMENT Recorded Feb 10, 2025
From: NOVALIS LIFESCIENCES INVESTMENTS II, LP
To: SHERLOCK BIOSCIENCES, INC.
Reel/Frame 070171/0448 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 68659 FRAME: 118. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Sep 24, 2024
From: SHERLOCK BIOSCIENCES, INC
To: NOVALIS LIFESCIENCES INVESTMENTS II, L.P.
Reel/Frame 069031/0946 →
SECURITY INTEREST Recorded Sep 23, 2024
From: SHERLOCK BIOSCIENCES, INC
To: NOVALIS LIFESCIENCE INVESTMENTS II, L.P.
Reel/Frame 068659/0118 →
RELEASE OF SECURITY INTEREST Recorded Jun 13, 2023
From: KDT SENSE HOLDINGS, LLC; CAMBRIDGE INNOVATION CAPITAL I LIMITED; EARLYBIRD HEALTH GMBH & CO. BETEILIGUNGS KG; MERCIA (GENERAL PARTNER) LIMITED; JONATHAN MILNER
To: SENSE BIODETECTION LIMITED
Reel/Frame 063931/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2023
From: LAMBLE, RALPH
To: SENSE BIODETECTION LIMITED
Reel/Frame 062685/0561 →
Priority Claims (4)
GB 2013353 · Aug 26, 2020 · national
GB 2013354 · Aug 26, 2020 · national
GB 2013356 · Aug 26, 2020 · national
GB 2013358 · Aug 26, 2020 · national
Continuity (1)
Related Publication 20230262872A1 · Aug 17, 2023
References Cited (32)
US 6781056B1 · O'Rourke et al. · 2004 [cited by applicant]
US 20080154179A1 · Cantor · 2008 [cited by examiner]
US 20100068822A1 · Heydenhauss · 2010 [cited by examiner]
US 20100304986A1 · Chen et al. · 2010 [cited by applicant]
US 20130210080A1 · Rajagopal et al. · 2013 [cited by applicant]
US 20160263577A1 · Ismagilov et al. · 2016 [cited by applicant]
US 20160271342A1 · Bronkhorst · 2016 [cited by examiner]
US 20170219556A1 · Ciampini · 2017 [cited by examiner]
US 20170304829A1 · Andreyev · 2017 [cited by examiner]
US 20180000158A1 · Ewing · 2018 [cited by examiner]
US 20190299210A1 · Lemoine et al. · 2019 [cited by applicant]
US 20200030795A1 · Pais et al. · 2020 [cited by applicant]
US 20230256441A1 · Lamble · 2023 [cited by applicant]
US 20230257834A1 · Lamble · 2023 [cited by applicant]
US 20240033736A1 · Lamble · 2024 [cited by applicant]
WO WO2009140373A2 · 2009 [cited by applicant]
WO WO2014164933A1 · 2014 [cited by applicant]
WO WO2016062788A1 · 2016 [cited by applicant]
WO WO2017093333A1 · 2017 [cited by applicant]
WO WO2022043689A1 · 2022 [cited by applicant]
WO WO2022043693A1 · 2022 [cited by applicant]
WO WO2022043696A1 · 2022 [cited by applicant]
WO WO2022043697A1 · 2022 [cited by applicant]
International Search Report & Written Opinion PCT Application No. PCT/GB2021/052213, dated Nov. 5, 2021, 11 pages. [cited by applicant]
International Search Report for PCT/GB21/52213, 3 pages (mailed May 11, 2021). [cited by applicant]
International Search Report for PCT/GB21/52219, 3 pages (Apr. 22, 2021). [cited by applicant]
International Search Report for PCT/GB21/52223, 4 pages (mailed Mar. 21, 2021). [cited by applicant]
International Search Report for PCT/GB21/52224, 4 pages (mailed Dec. 2, 2021). [cited by applicant]
Written Opinion for PCT/GB21/52213, 5 pages (mailed May 11, 2021). [cited by applicant]
Written Opinion for PCT/GB21/52219, 5 pages (Apr. 22, 2021). [cited by applicant]
Written Opinion for PCT/GB21/52223, 7 pages (mailed Mar. 21, 2021). [cited by applicant]
Written Opinion for PCT/GB21/52224, 6 pages (mailed Dec. 2, 2021). [cited by applicant]